Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Spesana
AddedFeb 16, 2024
UpdatedJun 18, 2026
Spesana

Spesana

Angel

Spesana, a biotech firm, streamlines healthcare with AI and automation, optimizing diagnostics, patient records, and data management.

HQ
Memphis, TN, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Founded in 2019, Spesana is a biotechnology company dedicated to revolutionizing healthcare through AI and automation. With a mission to optimize diagnostics, patient records, and data management, Spesana offers a comprehensive healthcare platform designed for health systems, molecular labs, biopharma, and revenue cycle stakeholders. Their platform streamlines the ordering of molecular diagnostics, aggregates patient records, generates instant MD referrals, and supports fully electronic tumor boards with data submissions to registrars.

Notable for its team that previously built the first oncology EMR and clinical decision support system, which was sold to GV-backed Flatiron Health, Spesana has attracted significant attention in the biotech industry. The company has achieved key milestones in creating an interoperability overlay that integrates healthcare data at the point of care. By enhancing existing workflows with digital tools, Spesana has made a substantial impact on providers, payers, life science partners, and patients, making healthcare better, faster, and smarter.

Spesana - Similar Companies

Healthspek logo

Healthspek

healthspek.com

Scispot logo

Scispot

scispot.io

Spektron Systems logo

Spektron Systems

SpIntellx logo

SpIntellx

predxbio.com

Speck logo

Speck

tryspeck.com

Spora Health logo

Spora Health

sporahealth.com

biospatial logo

biospatial

biospatial.io

Spoc Medical logo

Spoc Medical

Spreemo Health logo

Spreemo Health

Synapsica Healthcare logo

Synapsica Healthcare

Decoded Health logo

Decoded Health

decodedhealth.com

Sohar Health logo

Sohar Health

soharhealth.com

Notable Health logo

Notable Health

notablehealth.com

Pieces logo

Pieces

piecestech.com

HypaHub logo

HypaHub

Spesana - Quick Facts

Who are Spesana's competitors?

Companies similar to Spesana include Healthspek, Scispot, Spektron Systems and SpIntellx.

When was Spesana founded?

Spesana was founded in 2020.

Where is Spesana's headquarters located?

Spesana's headquarters is located in Memphis, TN, US.

When was Spesana's last funding round?

Spesana's most recent funding round was for $350k (USD) in May 2022.

How much has Spesana raised to-date?

As of May 27, 2022, Spesana has raised a total of $350k (USD).

How many employees does Spesana have?

Spesana has 26 employees as of Feb 5, 2024.

Spesana - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Automation
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Healthcare Platform
Tags
  • AI Operations
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software